Cargando…
A comprehensive survey of the mutagenic impact of common cancer cytotoxics
BACKGROUND: Genomic mutations caused by cytotoxic agents used in cancer chemotherapy may cause secondary malignancies as well as contribute to the evolution of treatment-resistant tumour cells. The stable diploid genome of the chicken DT40 lymphoblast cell line, an established DNA repair model syste...
Autores principales: | Szikriszt, Bernadett, Póti, Ádám, Pipek, Orsolya, Krzystanek, Marcin, Kanu, Nnennaya, Molnár, János, Ribli, Dezső, Szeltner, Zoltán, Tusnády, Gábor E., Csabai, István, Szallasi, Zoltan, Swanton, Charles, Szüts, Dávid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862131/ https://www.ncbi.nlm.nih.gov/pubmed/27161042 http://dx.doi.org/10.1186/s13059-016-0963-7 |
Ejemplares similares
-
The Genome of the Chicken DT40 Bursal Lymphoma Cell Line
por: Molnár, János, et al.
Publicado: (2014) -
A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms
por: Szikriszt, Bernadett, et al.
Publicado: (2021) -
Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut
por: Pipek, O., et al.
Publicado: (2017) -
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions
por: Zámborszky, J, et al.
Publicado: (2017) -
Erratum: Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions
por: Zámborszky, J, et al.
Publicado: (2017)